Immune-mediated pachymeningitis (Q90287)

From determinar.ia.br - Determine suas informações
Revision as of 17:14, 15 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.
Language Label Description Also known as
default for all languages
ID_1948607488
    English
    Immune-mediated pachymeningitis
    Hypertrophic pachymeningitis due to an immune-mediated process. The syndrome is characterised by localised or diffuse thickening of the dura mater, although all three membranes may be involved. The cranial dura, spinal dura or both may be involved. The clinical features reflect the part of the neuraxis affected and may include headache, cranial nerve palsies, ataxia, paraparesis, sensory loss and loss of sphincter control. Diagnosis may be confirmed by neuroimaging, spinal fluid analysis and meningeal biopsy.

      Statements

      CID11:ID_1948607488
      0 references
      dki-india-ID_1948607488
      0 references
      Concluído
      0 references
      13 August 2026
      0 references